1Finding RL,McNamara NK.Atypical Antipsychotics in the Treatment of Children and Adolescents:Clinical Applications[J].J Clin Psychiatry,2004,65(Suppl 6):30～44.
2Chen NC,Bedair HS,McKay B,et al.Clozapine in the treatment of aggression in an adolescent with autistict disorder[letter][J].J Clin Psychiatry,2001,62:479～480.
3McDougle CJ,Holmes JP,Carlson DC,et al.A double-blind,placebo-controlled study of risperidone in adults with disorder and other pervasive developmental disorders[J].Arch Gen Psychiatry,1998,55(7):633～641.
4McCraken JT,McGough J,Shah B,et al.Risperidone in children with autism and serious behavioral problems[J].N Engl J Med,2002,347:314～321.
5Hellings JA,Zarcone JR,Crandall K,et al.Weight gain in a controlled study of risperidone in children,adolescents and adults with mental retardation and autism[J].J Clild Adolesc Psychopharmacol,2001,11:229～238.
6Masi G,Cosenza A,Mucci M.Prolactin levels in young children with pervasive developmental disorders during risperidone treatment[J].J Child Adolesc Psychopharmacol,2001 ,11(4):389～394.
7Potenza MN,Holmes JP,Kanes SJ,et al.Olanzapine treatment of children,adolescents,and adults with pervasive developmental disorders:an open-label pilot study[J].J Clin Psychopharmacol,1999,19(1):37～44.
8Stavrakaki C,Antochi R,Emery PC.Olanzapine in the treatment of pervasive developmental:a case series analysis.J Psychiatry Neurosci,2004,29(1):57～60.
9McConville BJ,Arvanitis LA,Thyrum PT,et al.Pharmacokinetics,tolerability,and clinical effectiveness of quetiapine fumarate:an open-label trail in adolescents with psychotics disorders[J].J Clin Psychiatry,2000,61:252～260.
10Martin A,Koenig K,Scahill L,et al.Open-label quetiapine in the treatment of chlidren and adolecents with autistic disorder[J].J Child Adolesc Psychopharmacol, 1999,9:99～107.
